114 related articles for article (PubMed ID: 1019820)
1. L-asparaginase bound to collagen membrane in an extracorporeal device: an intermittent antitumor enzyme therapy delivery system.
Joyeuse R; Kim HC; Saidi P; McBride KJ; Jefferies SR; Bernath FR
Surg Forum; 1976; 27(62):115-6. PubMed ID: 1019820
[No Abstract] [Full Text] [Related]
2. Reduction of canine serum asparagine levels by L -asparaginase immobilized on collagen: a potential form of cancer chemotherapy.
Olanoff LS; Bernath FR; Venkatasubramanian K; Joyeuse R
Trans Am Soc Artif Intern Organs; 1975; 21():156-64. PubMed ID: 807012
[TBL] [Abstract][Full Text] [Related]
3. [A new antineoplastic drug: the L-asparaginase. Future possibilities of antitumor enzymotherapy].
Nervi C; Casale C; Cortese M
Policlinico Prat; 1969 Mar; 76(10):297-304. PubMed ID: 5252042
[No Abstract] [Full Text] [Related]
4. Perfusion trials with a collagen-immobilized enzyme in an extracorporeal reactor: activity, stability, and biocompatibility.
Olanoff LS; Venkatasubramanian K; Bernath FR; Joyeuse R
J Biomed Mater Res; 1977 Jan; 11(1):125-36. PubMed ID: 845182
[TBL] [Abstract][Full Text] [Related]
5. [Antineoplastic effect of L-asparaginase].
Opolski A
Postepy Hig Med Dosw; 1981; 35(2):177-87. PubMed ID: 7038650
[No Abstract] [Full Text] [Related]
6. [L-asparaginase--first specific cytostatic].
Marquardt H
Arzneimittelforschung; 1968 Nov; 18(11):1380-6. PubMed ID: 4885156
[No Abstract] [Full Text] [Related]
7. L-asparaginase--antileukemia agent.
Bukhari SZ; Yaqub M
J Pak Med Assoc; 1977 Jan; 27(1):262-4. PubMed ID: 19639
[TBL] [Abstract][Full Text] [Related]
8. [Antineoplastic activity of L-asparaginase].
Grgić Z
Lijec Vjesn; 1969 Jul; 91(7):783-6. PubMed ID: 4910066
[No Abstract] [Full Text] [Related]
9. Antitumor activity and other biologic properties of L-asparaginase (NSC-109229)-a review.
Adamson RH; Fabro S
Cancer Chemother Rep; 1968 Oct; 52(6):617-26. PubMed ID: 4895425
[No Abstract] [Full Text] [Related]
10. [The antitumor activity of L-asparaginase].
Adamson RH; Fabro S
Acta Vitaminol Enzymol; 1969; 23(3):111-24. PubMed ID: 4897937
[No Abstract] [Full Text] [Related]
11. Selective deficiency in collagen-induced platelet aggregation during L-asparaginase therapy.
Shapiro RS; Gerrard JM; Ramsay NK; Nesbit ME; Coccia PF; Stoddard SF; Plow EF; White JG; Krivit W
Am J Pediatr Hematol Oncol; 1980; 2(3):207-12. PubMed ID: 6933865
[TBL] [Abstract][Full Text] [Related]
12. Salivary hyperamylasemia after L-asparaginase therapy.
Adams LJ; Antonow DR; Ash R; McClain CJ
Cancer Treat Rep; 1985 Dec; 69(12):1437-8. PubMed ID: 2416440
[No Abstract] [Full Text] [Related]
13. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
Jacobs SP; Wodinsky I; Kensler CJ; Venditti JM
Cancer Chemother Rep; 1970 Oct; 54(5):329-35. PubMed ID: 5514622
[No Abstract] [Full Text] [Related]
14. A review of the preclinical antitumor activity and toxicology of L-asparaginase derived from E. coli.
Charles LM; Bono VH
Cancer Treat Rep; 1981; 65 Suppl 4():39-46. PubMed ID: 7049380
[No Abstract] [Full Text] [Related]
15. Is L-asparaginase an antiblastic agent?
Astaldi G
Haematologia (Budap); 1972; 6(4):433-46. PubMed ID: 4274316
[No Abstract] [Full Text] [Related]
16. L-asparaginase bound to collagen membranes: effect of glutaraldehyde crosslinking on stabilization of catalytic activity.
Jefferies SR; LaPresto P; Bernath FR
J Biomed Mater Res; 1978 Jul; 12(4):491-503. PubMed ID: 98529
[TBL] [Abstract][Full Text] [Related]
17. Preliminary studies with L-asparaginase bound to implantable bovine collagen heterografts: a potential long-term, sustained dosage, antitumor enzyme therapy system.
Jefferies SR; Richards R; Bernath FR
Biomater Med Devices Artif Organs; 1977; 5(4):337-54. PubMed ID: 23873
[TBL] [Abstract][Full Text] [Related]
18. Asparaginase and amino acids in cancer therapeutics. Cancer and Leukemia Group B Investigators.
Holland JF; Ohnuma T
Cancer Treat Rep; 1981; 65 Suppl 4():123-30. PubMed ID: 7049376
[TBL] [Abstract][Full Text] [Related]
19. Antileukemic effect of L-aspartyl-hydrazine.
Stern P; Valjevac K; Balenović K
Neoplasma; 1975; 22(1):69-71. PubMed ID: 1153038
[TBL] [Abstract][Full Text] [Related]
20. [Extracorporeal treatment with L-asparaginase (author's transl)].
Pralle H; Löffler H
Blut; 1977 Sep; 35(3):179-86. PubMed ID: 269743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
